| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/03/2006 | WO2005117938A3 Methods of treating ocular conditions |
| 08/03/2006 | WO2005103715A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 08/03/2006 | WO2005091753A3 Flexible vaccine assembly and vaccine delivery platform |
| 08/03/2006 | WO2005072710A3 Drugs and gene carrier particles that rapidly move through mucous barriers |
| 08/03/2006 | WO2005062890A3 Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel |
| 08/03/2006 | WO2005005622A3 Method of altering cell properties by administering rna |
| 08/03/2006 | WO2003014318A3 Methods for treating diabetes and other blood sugar disorders |
| 08/03/2006 | WO2002102319A3 Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue |
| 08/03/2006 | US20060172966 Immunostimulatory G, U-containing oligoribonucleotides |
| 08/03/2006 | US20060172965 RNAi-mediated inhibition of ocular targets |
| 08/03/2006 | US20060172964 Methods for reducing amyloid beta levels |
| 08/03/2006 | US20060172963 RNAi-mediated inhibition of ocular hypertension targets |
| 08/03/2006 | US20060172962 Modification of MYD88 splicing using modified oligonucleotides |
| 08/03/2006 | US20060172961 RNAi inhibition of serum amyloid a for treatment of glaucoma |
| 08/03/2006 | US20060172960 cellular senescence and immortalization; administering a telemerase inhibitor; reduced loss of telomere length; antiproliferative agents |
| 08/03/2006 | US20060172959 Selected rna motifs to include cell death and/or apoptosis |
| 08/03/2006 | US20060172958 Phospholipid scramblase 3 |
| 08/03/2006 | US20060172957 Antisense modulation of integrin beta 4 binding protein expression |
| 08/03/2006 | US20060172932 Novel erythropoietin receptor agonists |
| 08/03/2006 | US20060172930 Apoptosis-inducing gene and utilization of the same |
| 08/03/2006 | US20060172925 Thio-siRNA aptamers |
| 08/03/2006 | US20060172418 Hypercoiling polymers and their use in cellular delivery |
| 08/03/2006 | US20060172355 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172354 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/03/2006 | US20060172352 Nuclear matrix proteins |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060172343 Isolated using polymerase chain reaction using primers ; gene therapy; wound heaaling agents |
| 08/03/2006 | US20060172011 Medical treatment |
| 08/03/2006 | US20060171984 Device having hydration inhibitor |
| 08/03/2006 | US20060171965 Fusion proteins of mycobacterium tuberculosis |
| 08/03/2006 | US20060171964 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 08/03/2006 | US20060171956 Sphingoid polyalkylamine conjugates for hepatitis B virus vaccination |
| 08/03/2006 | US20060171953 Tumour-specific animal proteins |
| 08/03/2006 | US20060171935 Protecting cell therapy for neurological disorders including Parkinson's disease |
| 08/03/2006 | US20060171934 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 08/03/2006 | US20060171933 Cell culture |
| 08/03/2006 | US20060171927 recruiting neurons to the brain, and treating a neurodegenerative condition by injecting nucleic acid construct intraventricularly into subject's brain; Huntington's Disease |
| 08/03/2006 | US20060171926 Injecting adeno-associated virus vectors into central nervous system; transducing cells located at distal site for translation of biologically active molecule and expression; Niemann-Pick A disease |
| 08/03/2006 | US20060171925 Expression vector includes insert of dna which codes for exogenous protein and adenovirus dna having deletion from nucleotides 356-4020; production of recombinant proteins; gene therapy against tumors and cancer |
| 08/03/2006 | US20060171924 Bidirectional promoters for small RNA expression |
| 08/03/2006 | US20060171923 inhibit transcription factors Pbx1- or HMG I-mediated retroviral gene expression and to inhibit HIV replication in vivo; novel targets for identification of agents that regulate gene expression of retroviruses; |
| 08/03/2006 | US20060171922 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 08/03/2006 | US20060171917 Vaccine formulations for intradermal delivery comprising adjuvants and antigenic agents |
| 08/03/2006 | US20060171899 Water-stabilized aerosol formulation system and method of making |
| 08/03/2006 | DE102005005528A1 Using nucleic acid to prepare injectable agent for transportation to retinal ganglion cells, useful in treatment of glaucoma and diabetic complications of the eye, acts especially by RNA intereference |
| 08/03/2006 | CA2596230A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | CA2596227A1 Improved modalities for the treatment of degenerative diseases of the retina |
| 08/03/2006 | CA2596058A1 Method of producing coated fine particles |
| 08/03/2006 | CA2595942A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 08/03/2006 | CA2595896A1 Inhibitor nucleic acids |
| 08/03/2006 | CA2595894A1 Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment |
| 08/03/2006 | CA2595874A1 The new use of recombinant adenovirus-p53 agent in treatment of tumor patients |
| 08/03/2006 | CA2594919A1 Rnai modulation of the nogo-l or nogo-r gene and uses thereof |
| 08/03/2006 | CA2592562A1 Nucleic acids for apoptosis of cancer cells |
| 08/02/2006 | EP1686181A2 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains |
| 08/02/2006 | EP1686180A2 Method of purification of recombinant viral vectors containing a therapeutic gene |
| 08/02/2006 | EP1686172A2 Myocardial grafts and cellular compositions useful for same |
| 08/02/2006 | EP1685847A1 Beta-amyloid-analogue-T-cell epitop vaccine |
| 08/02/2006 | EP1685842A2 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 08/02/2006 | EP1685261A2 Highly parallel dna synthesiser based on matrices |
| 08/02/2006 | EP1685254A2 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 08/02/2006 | EP1685251A2 Nucleic acid constructs |
| 08/02/2006 | EP1685147A2 Modulation of sglt2 expression |
| 08/02/2006 | EP1684736A1 Dna damage repair inhibitors for treatment of cancer |
| 08/02/2006 | EP1684690A2 Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders |
| 08/02/2006 | EP1560931A4 Functional and hyperfunctional sirna |
| 08/02/2006 | EP1420815B1 Beta-amyloid-analogue - t-cell epitop vaccine |
| 08/02/2006 | EP1397154B1 Abin-mediated hepatitis protection |
| 08/02/2006 | EP1341565B1 Drug delivery compositions and coated medical devices |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1058562B1 Compositions and methods of treating tumors |
| 08/02/2006 | EP1056878B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 08/02/2006 | EP0939621B1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 08/02/2006 | EP0914339B1 RET LIGAND 3 (RetL3) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 08/02/2006 | EP0696206B1 Adenoviruses having modified fiber proteins |
| 08/02/2006 | CN1813066A Novel beta-actin and rps21 promoters and uses thereof |
| 08/02/2006 | CN1812766A Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
| 08/02/2006 | CN1810839A Anti-hepatitis B virus fusion protein and its coding gene and application |
| 08/02/2006 | CN1810823A Specific chicken CpG ODN and its application |
| 08/02/2006 | CN1267553C Haemophilus transferrin receptor genes |
| 08/02/2006 | CN1267552C Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 08/02/2006 | CN1267551C Expression of recombinant mature lysostaphin |
| 08/02/2006 | CN1267550C Vascular endothelial growth factor 2 |
| 08/01/2006 | USRE39219 Isolated Dna |
| 08/01/2006 | US7084267 for the regulation of telomerase RNA genes, including the Sp family of transcription factors |
| 08/01/2006 | US7084249 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 08/01/2006 | US7084242 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol |
| 08/01/2006 | US7083981 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083943 Polynucleotides related to murine anti-idiotype antibody 11D10 and methods of use thereof |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083934 Method for detecting transferrin receptor-like proteins |
| 08/01/2006 | US7083927 Comprises nucleotide sequences coding ubiquitin protein ligase complex polypeptides for diagnosid and treatment of cancer, immune/inflammatory and neurological disorders |
| 08/01/2006 | US7083794 Selecting for a strain of bacteria having an RpoS+ phenotype, inactivating mutations which render the strain attenutated, and a recombinant gene encoding the product |
| 08/01/2006 | US7083791 Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides |
| 08/01/2006 | US7083788 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 08/01/2006 | US7083783 Administering adenosine 5"-diphosphate transferase proteins; reducing eye pressure |
| 07/27/2006 | WO2006079068A2 Compositions and methods for studying and treating inflammatory diseases and disorders |
| 07/27/2006 | WO2006079014A2 Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids |
| 07/27/2006 | WO2006078880A2 Inducible sirna expression cassette and method of use |